We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




EMR-Based Tool Predicts Graft Failure After Kidney Transplant

By HospiMedica International staff writers
Posted on 12 Dec 2025

Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. More...

Although a successful transplant is expected to last about a decade, nearly one in four kidney grafts fail within five years, often without early warning signs. Clinicians currently lack reliable ways to identify which patients are most at risk of losing a transplanted kidney. A new study now shows that routinely collected kidney function data can be used to dynamically predict graft failure risk years before it happens.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) have developed an electronic medical record (EMR)–based prediction model that continuously updates a patient’s risk of graft failure using changes in estimated glomerular filtration rate, a standard blood test that reflects how well a transplanted kidney is functioning. The approach allows risk to be recalculated every time new lab results become available.

The model was built using data from 1,114 deceased-donor kidney transplant recipients and validated across multiple large datasets, including national transplant registries and real-world hospital records. Investigators analyzed repeated kidney function measurements over time and linked these trajectories to graft failure, defined as a return to dialysis or the need for a second transplant within three years.

The results, published in the Clinical Journal of the American Society of Nephrology, showed that the model could effectively distinguish high-risk from low-risk patients. Predictive accuracy reached 0.70 just three months after transplant and improved to 0.90 by 30 months, demonstrating strong performance well before clinical failure occurred.

By identifying patients at elevated risk, the tool could support earlier interventions such as closer monitoring, adjustments to immunosuppressive therapy, and counseling about future transplant needs. At the same time, patients at low risk could safely transition back to routine nephrology care closer to home, freeing transplant center resources.

Researchers now plan to test the model in everyday clinical practice and expand it by incorporating additional health data, including clinical events and other laboratory markers. These efforts aim to further improve early detection of graft injury and long-term transplant outcomes.

“The results from this study can be readily implemented at transplant centers to streamline care of kidney transplant recipients by providing updated risk predictions as new data become available,” said Chirag Parikh, MD, PhD, the study’s senior author. “There could also be future downstream models developed to predict other infections and immunologic complications.”

Related Links:
Johns Hopkins Medicine


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Blood Gas Analyzer
i-Check200
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.